On June 8, 2022 Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel T cell-based cancer immunotherapies, reported that senior leadership plans to present at the following conferences in June (Press release, Iovance Biotherapeutics, JUN 8, 2022, View Source [SID1234615798]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Jefferies Healthcare Conference
Fireside Chat: June 9 at 4 p.m. ET
New York, NY
JMP Global Healthcare Conference
Fireside Chat: June 15 at 2:30 p.m. ET
New York, NY
Goldman Sachs Global Healthcare Conference
Fireside Chat: June 15 at 6:20 p.m. ET
Palos Verdes, CA
Stifel Virtual Cell Therapy Conference
Panel: June 29 at 3:30 p.m. ET
Virtual
The live and archived webcasts, and the most recent corporate presentation, will be available at View Source